[go: up one dir, main page]

BG94824A - Таблетка, съдържаща натриев 2-меркаптоетансулфонат (месна), като активно вещество и метод за получаването й - Google Patents

Таблетка, съдържаща натриев 2-меркаптоетансулфонат (месна), като активно вещество и метод за получаването й

Info

Publication number
BG94824A
BG94824A BG094824A BG9482491A BG94824A BG 94824 A BG94824 A BG 94824A BG 094824 A BG094824 A BG 094824A BG 9482491 A BG9482491 A BG 9482491A BG 94824 A BG94824 A BG 94824A
Authority
BG
Bulgaria
Prior art keywords
mercaptoethanesulfonate
preparation
active substance
mesna
containing sodium
Prior art date
Application number
BG094824A
Other languages
English (en)
Other versions
BG60851B1 (bg
Inventor
Dieter Sauerbier
Juergen Engel
Eckhard Milsmann
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of BG94824A publication Critical patent/BG94824A/bg
Publication of BG60851B1 publication Critical patent/BG60851B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Таблетката и методът намират приложение във фармацевтичната промишленост. Получената по метода таблетка е стабилна и има добър вкус. Съдържа в тегл.ч. 0,01-1,0 свързващо вещество, 0,03-0,4 разпадащо вещество, 0,01-0,2 смазващо вещество и 0,1-1,0 пълнител, а за получаването на ефервесцентна таблетка и от 0,05 до 30,0 от обичайната, физиологически безвредна шумяща смес, като всички количества са дадени по отношение на 1 тегл.ч. от активното вещество, и от 10 до 80% тегл. 2-меркаптоетансулфонат. 4 претенции
BG94824A 1990-07-16 1991-07-16 Таблетка, съдържаща натриев 2-меркаптоетансулфонат (месна), като активно вещество и метод за получаването й BG60851B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (2)

Publication Number Publication Date
BG94824A true BG94824A (bg) 1993-12-24
BG60851B1 BG60851B1 (bg) 1996-05-31

Family

ID=25895027

Family Applications (2)

Application Number Title Priority Date Filing Date
BG94824A BG60851B1 (bg) 1990-07-16 1991-07-16 Таблетка, съдържаща натриев 2-меркаптоетансулфонат (месна), като активно вещество и метод за получаването й
BG96200A BG60901B1 (bg) 1990-07-16 1992-04-08 Гранулат,съдържащ натриев 2-меркаптоетансулфонаткато активно вещество и метод за получаването му

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG96200A BG60901B1 (bg) 1990-07-16 1992-04-08 Гранулат,съдържащ натриев 2-меркаптоетансулфонаткато активно вещество и метод за получаването му

Country Status (31)

Country Link
US (1) US5262169A (bg)
EP (1) EP0468245B1 (bg)
JP (1) JP3068894B2 (bg)
KR (1) KR100189666B1 (bg)
CN (1) CN1072484C (bg)
AT (1) ATE104548T1 (bg)
AU (1) AU638586B2 (bg)
BG (2) BG60851B1 (bg)
CA (1) CA2047027C (bg)
DE (2) DE59101431D1 (bg)
DK (1) DK0468245T3 (bg)
EG (1) EG20019A (bg)
ES (1) ES2063412T3 (bg)
FI (1) FI97949C (bg)
HK (1) HK129894A (bg)
HR (1) HRP920889B1 (bg)
HU (1) HU206630B (bg)
IE (1) IE65373B1 (bg)
IL (1) IL98836A (bg)
LT (1) LT3527B (bg)
LV (1) LV10040B (bg)
MC (1) MC2273A1 (bg)
MX (1) MX174407B (bg)
NO (1) NO178362C (bg)
NZ (1) NZ238941A (bg)
PT (1) PT98325B (bg)
RO (1) RO113713B1 (bg)
RU (1) RU2070040C1 (bg)
SG (1) SG142394G (bg)
SI (1) SI9111226A (bg)
ZA (1) ZA915515B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE160696T1 (de) * 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.

Also Published As

Publication number Publication date
CA2047027C (en) 1996-09-17
CA2047027A1 (en) 1992-01-17
HU206630B (en) 1992-12-28
HK129894A (en) 1994-12-02
LV10040B (en) 1995-06-20
ES2063412T3 (es) 1995-01-01
CN1072484C (zh) 2001-10-10
NO912771D0 (no) 1991-07-15
AU8044591A (en) 1992-01-16
SI9111226A (en) 1995-04-30
MC2273A1 (fr) 1993-06-23
KR920002154A (ko) 1992-02-28
IE912463A1 (en) 1992-01-29
NO178362B (no) 1995-12-04
ZA915515B (en) 1992-04-29
RO113713B1 (ro) 1998-10-30
CN1058337A (zh) 1992-02-05
LT3527B (en) 1995-11-27
KR100189666B1 (ko) 1999-06-01
MX174407B (es) 1994-05-13
BG96200A (bg) 1993-12-24
IE65373B1 (en) 1995-10-18
NZ238941A (en) 1993-03-26
BG60901B1 (bg) 1996-06-28
ATE104548T1 (de) 1994-05-15
FI913409A0 (fi) 1991-07-15
NO178362C (no) 1996-03-13
SG142394G (en) 1995-01-13
LTIP920A (en) 1995-03-27
IL98836A (en) 1994-11-28
US5262169A (en) 1993-11-16
JP3068894B2 (ja) 2000-07-24
JPH04230319A (ja) 1992-08-19
AU638586B2 (en) 1993-07-01
IL98836A0 (en) 1992-07-15
DK0468245T3 (da) 1994-05-16
NO912771L (no) 1992-01-17
EP0468245B1 (de) 1994-04-20
PT98325B (pt) 1999-01-29
FI97949B (fi) 1996-12-13
DE59101431D1 (de) 1994-05-26
FI913409A (fi) 1992-01-17
HUT59317A (en) 1992-05-28
DE4122167A1 (de) 1992-01-23
PT98325A (pt) 1992-05-29
HU912374D0 (en) 1991-12-30
HRP920889A2 (en) 1996-04-30
HRP920889B1 (en) 1998-02-28
LV10040A (lv) 1994-05-10
EG20019A (en) 1997-01-30
RU2070040C1 (ru) 1996-12-10
EP0468245A1 (de) 1992-01-29
BG60851B1 (bg) 1996-05-31
FI97949C (fi) 1997-03-25

Similar Documents

Publication Publication Date Title
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
EA199700110A1 (ru) Композиция с высоким содержанием ацетаминофена для прямого прессования
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
KR900013952A (ko) 경구투여용 이부프로펜 조성물
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
UA41346C2 (uk) Фармацевтична композиція, яка містить флуоксетин або його сіль, таблетка на її основі, спосіб виробництва таблетки, яка диспергується
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
BG94824A (bg) Таблетка, съдържаща натриев 2-меркаптоетансулфонат (месна), като активно вещество и метод за получаването й
KR920005984A (ko) 푸란 유도체를 함유하는 제약 조성물
EG19218A (en) Stable solutions of rebeccamycin analogs and preparation thereof
ES8401929A1 (es) Procedimiento de preparar derivados de p-acilaminofenol.
JPS5726587A (en) Stabilization of ascorbic acid oxidase
TNSN94110A1 (fr) Procede de preparation de compositions orales contenant des quinolones
KR970061084A (ko) 닭의 발육을 촉진하는 방법
GB1449441A (en) Agnets for lowering the lipid level in plasma
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
KR870003721A (ko) 저나트륨 식염의 제조방법
KR830003885A (ko) 요오드 고함유란(高含有卵)을 주성분으로 하는 지질대사 개선용 조성물의 제조방법
JPS5618568A (en) Prevention of occurrence of mold and rottenness of mirin-seasoning
RU2004235C1 (ru) Способ профилактики острых респираторных болезней тел т
TH3206A (th) สารแขวนลอยซูครัลเฟท
RU93043302A (ru) Способ получения раствора антиоксидантов